Repeated low-level red-light therapy lowers myopia onset risk in youngsters: Study
Written By : Jacinthlyn Sylvia
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2022-09-18 15:00 GMT | Update On 2022-09-18 15:00 GMT
Advertisement
Australia: A new study published in the Ophthalmology journal suggests that repeated low-level red-light (RLRL) therapy at 100% power significantly slowed the onset of myopia in myopic youngsters over the course of six months.
Despite the fact that open-label research has hampered earlier trials, repeated low-level red light therapy is developing as a treatment for controlling myopia. The goal of this study by Jing Dong and colleagues was to evaluate the effectiveness and safety of RLRL treatment in slowing the progression of myopia to a sham device that had just 10% of the original power.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.